Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine

Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine

Introduction: In the field of headaches, onabotulinumtoxinA (onabotA) is well established as a treatment for chronic migraine (CM). In recent years, it has been used increasingly to treat other primary headaches (high-frequency episodic migraine, trigeminal-autonomic cephalalgias, nummular headache)...

Full description

Bibliographic Details
Main Authors: S. Santos-Lasaosa, M.L. Cuadrado, A.B. Gago-Veiga, A.L. Guerrero-Peral, P. Irimia, J.M. Láinez, R. Leira, J. Pascual, J. Porta-Etessam, M. Sánchez del Río, J. Viguera Romero, P. Pozo-Rosich
Format: Article
Language:English
Published: Elsevier España 2020-10-01
Series:Neurología (English Edition)
Subjects:
Cefalea en racimo
Cefalea numular
Hemicránea continua
Migraña
Neuralgia del trigémino
OnabotulinumtoxinA
Online Access:http://www.sciencedirect.com/science/article/pii/S2173580820301620

Internet

http://www.sciencedirect.com/science/article/pii/S2173580820301620

Similar Items